The Vietnamese drug regulator has banned 39 Indian drug companies. The drug companies of South Korea, Bangladesh are also in blacklist.
Aurobindo Pharma, Cadila, Mcleods Pharmaceuticals are also included in Indian drug companies that have been blacklisted by Vietnam for quality standard violations. The regulator has listed the names of blacklisted companies on its website without specifying in detail the reason behind the ban.
Antibiotics made by Aurobindo and Macleods, and Cadila’s anti-rabies vaccine Lyssavac are some of the drugs that have been banned. Lyssavac vaccine was also banned by World Health Organisation in January this year. A representative of a pharma company that has been banned said, the Vietnamese regulator took samples from retail stores, which did not follow proper storage methods.
“Our sales to Vietnam is just around $1 million in a year and hence does not mater much. Regulatory authorities have introduced additional steps for testing before the release of the batch,“ said an investor relation spokesperson for Aurobindo Pharma to ET`s email query.
A senior executive of another blacklisted company said, “Certain storage conditions need to be maintained for some products. Our control samples are absolutely fine. The products were banned on the basis of one sample. We will approach the Vietnamese regulator soon.“